The Dual Incretin Specialist: Tirzepatide
Tirzepatide is a high-purity, synthetic research peptide engineered as a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. By simultaneously activating two distinct incretin pathways, it offers researchers a potent tool for studying metabolic optimization, glucose regulation, and systemic weight management dynamics.
Note: This product is intended for research use only.
Related
Tirzepatide operates via a dual-action signaling mechanism that targets key metabolic pathways throughout the body:
- GLP-1 Activation: Signals key central nervous system receptors to suppress appetite, delays gastric emptying to prolong feelings of fullness, and stimulates glucose-dependent insulin secretion from the pancreas.
- GIP Activation: Works synergistically alongside GLP-1 pathways to further refine insulin sensitivity, enhance lipid breakdown, and improve overall metabolic efficiency.
Related
Reviews
There are no reviews yet